Search Results 211-220 of 16489 for Pulmonary hypertension
If left untreated, patients with pulmonary hypertension (PH) resulting from left heart disease (LHD) have a life expectancy of less than five years, ...
... Hepatopulmonary syndrome, Pulmonary hypertension, Pulmonary fibrosis, Cystic fibrosis, Interstitial lung disease, Pulmonary valve disease, Advanced lung disease ...
Mayo Clinic is a Pulmonary Fibrosis Foundation Care Center. Pulmonary Hypertension Association (PHA). Mayo Clinic is one of a few select U.S. medical centers ...
... pulmonary hypertension (CTEPH) not amenable to pulmonary endarterectomy (PEA). Participation eligibility. Participant eligibility includes age, gender, type ...
... pulmonary artery hypertension diagnosed by right heart catheterization. The primary aim is to determine the correlation of other echocardiographic ...
High blood pressure in the pulmonary arteries (pulmonary hypertension); Inflammation of the heart muscle (myocarditis). Risk factors. Risk factors for bundle ...
Clinical Trials · A Study Of Rodatristat Ethyl In Patients With Pulmonary Arterial Hypertension (ELEVATE 2) · More about research at Mayo Clinic · Mayo Clinic ...
... pulmonary arterial hypertension. Patients will be in the study for 5 1/2 months, 4 months of which they will receive macitentan, 10 mg, once daily. The ...
To evaluate the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in ...
Pulmonary hypertension: Diagnosis and management of pulmonary vascular disease in infants, children, and adolescents. Bronchopulmonary dysplasia: Long-term ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.